Maassen VanDenBrink A - Search Results

1

Chromosomal localization of the 5-HT1F receptor gene: no evidence for involvement in response to sumatriptan in migraine patients.

Maassen VanDenBrink A, Vergouwe MN, Ophoff RA, Naylor SL, Dauwerse HG, Saxena PR, Ferrari MD, Frants RR. Maassen VanDenBrink A, et al. Am J Med Genet. 1998 Jun 5;77(5):415-20. Am J Med Genet. 1998. PMID: 9632173

2

Interictal cortical hyperexcitability in migraine patients demonstrated with transcranial magnetic stimulation.

van der Kamp W, Maassen VanDenBrink A, Ferrari MD, van Dijk JG. van der Kamp W, et al. Among authors: maassen vandenbrink a. J Neurol Sci. 1996 Jul;139(1):106-10. doi: 10.1016/s0022-510x(96)00044-5. J Neurol Sci. 1996. PMID: 8836980

3

Investigations with GMC2021 in experimental models predictive of antimigraine activity and coronary side-effect potential.

Saxena PR, De Vries P, Heiligers JP, Maassen VanDenBrink A, Bax WA, Barf T, Wikström H. Saxena PR, et al. Among authors: maassen vandenbrink a. Eur J Pharmacol. 1996 Sep 19;312(1):53-62. doi: 10.1016/0014-2999(96)00443-8. Eur J Pharmacol. 1996. PMID: 8891578

4

Effects of S20749, a close analogue of sumatriptan, on porcine carotid haemodynamics and human isolated coronary artery.

Saxena PR, Maassen vandenBrink A, Heiligers JP, Scalbert E, Lemaitre BG. Saxena PR, et al. Among authors: maassen vandenbrink a. Pharmacol Toxicol. 1996 Oct;79(4):199-204. doi: 10.1111/j.1600-0773.1996.tb02088.x. Pharmacol Toxicol. 1996. PMID: 8899861

5

Augmented contraction of the human isolated coronary artery by sumatriptan: a possible role for endogenous thromboxane.

Maassen VanDenBrink A, Bax WA, Ferrari MD, Zijlstra FJ, Bos E, Saxena PR. Maassen VanDenBrink A, et al. Br J Pharmacol. 1996 Nov;119(5):855-62. doi: 10.1111/j.1476-5381.1996.tb15751.x. Br J Pharmacol. 1996. PMID: 8922732 Free PMC article.

6

Effects of avitriptan, a new 5-HT 1B/1D receptor agonist, in experimental models predictive of antimigraine activity and coronary side-effect potential.

Saxena PR, De Vries P, Wang W, Heiligers JP, Maassen vandenBrink A, Bax WA, Yocca FD. Saxena PR, et al. Among authors: maassen vandenbrink a. Naunyn Schmiedebergs Arch Pharmacol. 1997 Feb;355(2):295-302. doi: 10.1007/pl00004946. Naunyn Schmiedebergs Arch Pharmacol. 1997. PMID: 9050026 Free article.

7

Interictal cortical excitability to magnetic stimulation in familial hemiplegic migraine.

van der Kamp W, MaassenVanDenBrink A, Ferrari MD, van Dijk JG. van der Kamp W, et al. Neurology. 1997 May;48(5):1462-4. doi: 10.1212/wnl.48.5.1462. Neurology. 1997. PMID: 9153495

8

5-HT1B receptor polymorphism and clinical response to sumatriptan.

MaassenVanDenBrink A, Vergouwe MN, Ophoff RA, Saxena PR, Ferrari MD, Frants RR. MaassenVanDenBrink A, et al. Headache. 1998 Apr;38(4):288-91. doi: 10.1046/j.1526-4610.1998.3804288.x. Headache. 1998. PMID: 9595868

9

Coronary side-effect potential of current and prospective antimigraine drugs.

MaassenVanDenBrink A, Reekers M, Bax WA, Ferrari MD, Saxena PR. MaassenVanDenBrink A, et al. Circulation. 1998 Jul 7;98(1):25-30. doi: 10.1161/01.cir.98.1.25. Circulation. 1998. PMID: 9665056 Free article.

10

BMS-181885, a 5-HT1B/1D receptor ligand, in experimental models predictive of antimigraine activity and coronary side-effect potential.

Saxena PR, De Vries P, Heiligers JP, Bax WA, Maassen VanDenBrink A, Yocca FD. Saxena PR, et al. Among authors: maassen vandenbrink a. Eur J Pharmacol. 1998 Jun 26;351(3):329-39. doi: 10.1016/s0014-2999(98)00325-2. Eur J Pharmacol. 1998. PMID: 9721025

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

195 results

Search Page

Filters